(Q34344685)

1 August 2017

1 reference

title

AIDS policy modeling for the 21st century: an overview of key issues (English)

1 reference

1 August 2017

Rauner MS

1

1 reference

1 August 2017

Brandeau ML

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 September 2001

1 reference

Health Care Management Science

1 August 2017

published in

1 reference

1 August 2017

volume

4

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

165-180

1 reference

AIDS and the limits of control: public health orders, quarantine, and recalcitrant behavior

1 August 2017

cites work

1 reference

12 December 2020

Implicit valuation of a blood-exclusion decision

1 reference

12 December 2020

Mathematical and statistical studies of the epidemiology of HIV.

1 reference

12 December 2020

Concurrent partnerships and the spread of HIV

1 reference

12 December 2020

Prostitution, AIDS, and preventive health behavior

1 reference

12 December 2020

Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits

1 reference

12 December 2020

Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group

1 reference

12 December 2020

Reported changes in sexual behavior in response to AIDS in the United States.

1 reference

12 December 2020

Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy

1 reference

12 December 2020

Israel's ban on use of Ethiopians' blood: how many infectious donations were prevented?

1 reference

12 December 2020

1 reference

12 December 2020

Economic evaluation of HIV prevention programs

1 reference

12 December 2020

Universal HIV screening of pregnant women in England: cost effectiveness analysis

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

The cost-effectiveness of preventing AIDS-related opportunistic infections

1 reference

12 December 2020

International travel and AIDS.

1 reference

12 December 2020

Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. AIDS/TB Committee of the Society for Healthcare Epidemiology of America

1 reference

12 December 2020

Drugs, sex and HIV : a mathematical model for New York City

1 reference

12 December 2020

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

1 reference

12 December 2020

Screening pregnant women for HIV antibody: cost-benefit analysis.

1 reference

12 December 2020

Cost-effectiveness analysis of screening health care workers for HIV.

1 reference

12 December 2020

Proposed initiatives for healthy children orphaned by AIDS.

1 reference

12 December 2020

Modelling the spread of HIV in social networks of injecting drug users

1 reference

12 December 2020

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

12 December 2020

Cost-effectiveness of HIV screening in acute care settings

1 reference

12 December 2020

Sociometric risk networks and risk for HIV infection

1 reference

12 December 2020

Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries.

1 reference

12 December 2020

Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.

1 reference

12 December 2020

Combined antiviral treatment in HIV infection. Is it value for money?

1 reference

12 December 2020

Prevention of HIV infection

1 reference

12 December 2020

The effects of the AIDS epidemic on the safety of the nation's blood supply.

1 reference

12 December 2020

AIDS: what does economics have to offer?

1 reference

12 December 2020

Strategies for providing care and support to children orphaned by AIDS.

1 reference

12 December 2020

Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting

1 reference

12 December 2020

HIV antibody screening among immigrants: a cost-benefit analysis

1 reference

12 December 2020

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting

1 reference

12 December 2020

Evaluation of a hospital admission HIV antibody voluntary screening program

1 reference

12 December 2020

Evaluating the cost-effectiveness of clinical and public health measures

1 reference

12 December 2020

Male-to-female transmission of human immunodeficiency virus

1 reference

12 December 2020

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review

1 reference

12 December 2020

Are advances in treatment changing views about high-risk sex?

1 reference

12 December 2020

Relapse prevention as an interventive model for HIV risk reduction in gay and bisexual men.

1 reference

12 December 2020

Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics

1 reference

12 December 2020

Proceedings: Cost savings/benefit analysis of drug abuse treatment

1 reference

12 December 2020

Cost-effectiveness of prophylactic AZT following needlestick injury in health care workers

1 reference

12 December 2020

Behavior changes & disease prevention: MCW research shows effectiveness of HIV/AIDS risk reduction interventions. Medical College of Wisconsin

1 reference

12 December 2020

QALYs versus HYEs--what's right and what's wrong. A review of the controversy

1 reference

12 December 2020

The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.

1 reference

12 December 2020

Reducing needlesticks and blood exposure: tracking, training, technology

1 reference

12 December 2020

Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents

1 reference

12 December 2020

International migration and control of communicable diseases

1 reference

12 December 2020

An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA)

1 reference

12 December 2020

Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997

1 reference

12 December 2020

Therapeutic advances: protease inhibitors for the treatment of HIV-1 infection

1 reference

12 December 2020

HIV transmission and the cost-effectiveness of methadone maintenance.

1 reference

12 December 2020

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

1 reference

12 December 2020

Patterns of sexual behavior change among homosexual/bisexual men--selected U.S. sites, 1987-1990.

1 reference

12 December 2020

Screening surgeons for HIV infection. A cost-effectiveness analysis

1 reference

12 December 2020

Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates

1 reference

12 December 2020

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation

1 reference

12 December 2020

Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system

1 reference

12 December 2020

The cost-effectiveness of HIV testing of physicians and dentists in the United States

1 reference

12 December 2020

The case for a full cost-benefit analysis of preoperative HIV screening

1 reference

12 December 2020

AIDS, the law and civil liberties.

1 reference

12 December 2020

Building and testing an effective HIV vaccine

1 reference

12 December 2020

An economic evaluation of mandatory premarital testing for HIV

1 reference

12 December 2020

Sexual transmission of HIV: infectiousness and prevention

1 reference

12 December 2020

Recommendations for surgical therapy planning and interventions in patients with AIDS

1 reference

12 December 2020

Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis

1 reference

12 December 2020

Quantification of HIV in semen: correlation with antiviral treatment and immune status

1 reference

12 December 2020

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

12 December 2020

H.I.V. testing for newborns debated anew

1 reference

12 December 2020

Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa

1 reference

12 December 2020

Screening strategies to inhibit the spread of AIDS.

1 reference

12 December 2020

Resource allocation for epidemic control over short time horizons.

1 reference

12 December 2020

Antiretroviral therapy in sub-Saharan Africa

1 reference

12 December 2020

Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.

1 reference

12 December 2020

Cuba's response to the HIV epidemic

1 reference

12 December 2020

Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.

1 reference

12 December 2020

Changing therapy in HIV.

1 reference

12 December 2020

Letter: Economics of methadone maintenance

1 reference

12 December 2020

Screening women of childbearing age for human immunodeficiency virus. A cost-benefit analysis

1 reference

12 December 2020

Benefits of HIV screening of blood transfusions in Zambia

1 reference

12 December 2020

The epidemiological and economic consequences of AIDS clinical trials.

1 reference

12 December 2020

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

12 December 2020

HIV transmission. AIDS researchers look to Africa for new insights

1 reference

12 December 2020

Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence

1 reference

12 December 2020

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

12 December 2020

Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV

1 reference

12 December 2020

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

12 December 2020

Estimating the prevalence of injecting drug users on the basis of Markov models of the HIV/AIDS epidemic: applications to Italian data

1 reference

12 December 2020

Whose blood is safer? The effect of the stage of the epidemic on screening for HIV

1 reference

12 December 2020

Relapse in sexual behavior among homosexual men: a 2-year follow-up from the Chicago MACS/CCS.

1 reference

12 December 2020

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Preven

1 reference

12 December 2020

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

12 December 2020

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

12 December 2020

[Prenatal care of a HIV-1-positive pregnancy and birth]

1 reference

12 December 2020

Five minutes with the Governor.

1 reference

12 December 2020

Trends in perinatal transmission of HIV/AIDS in the United States

1 reference

12 December 2020

Long-run impacts of AIDS.

1 reference

12 December 2020

Modeling zidovudine therapy: a cost-effectiveness analysis.

1 reference

12 December 2020

[Risk of accidental contamination by the human immunodeficiency virus (HIV): review and management]

1 reference

12 December 2020

Perinatal HIV-1 transmission: recent advances and therapeutic interventions.

1 reference

12 December 2020

Economic evaluation of HIV testing among intravenous drug users. An analytic framework and its application to Italy.

1 reference

12 December 2020

Relapse from safer sex: the next challenge for AIDS prevention efforts.

1 reference

12 December 2020

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection

1 reference

12 December 2020

Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.

1 reference

12 December 2020

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

12 December 2020

HIV-1 protease inhibitors. A review for clinicians

1 reference

12 December 2020

Economic analysis of needle exchange

1 reference

12 December 2020

Female-to-male transmission of human immunodeficiency virus

1 reference

12 December 2020

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

12 December 2020

High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors.

1 reference

12 December 2020

Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area. The Paris-Tours study group of antenatal transmission of HIV, Group '9 maternites'

1 reference

12 December 2020

Policies of containment: immigration in the era of AIDS.

1 reference

12 December 2020

Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?

1 reference

12 December 2020

Interpretation of cost-effectiveness analyses

1 reference

12 December 2020

One world, one hope: the cost of providing antiretroviral therapy to all nations

1 reference

12 December 2020

Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis

1 reference

12 December 2020

Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention

1 reference

12 December 2020

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.

1 reference

12 December 2020

Effect of the U.S. Embargo and Economic Decline on Health in Cuba

1 reference

12 December 2020

The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?

1 reference

12 December 2020

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

1 reference

12 December 2020

Costs and benefits of HIV-1 antibody testing of donated blood

1 reference

12 December 2020

Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols.

1 reference

12 December 2020

Reducing perinatal HIV transmission in developing countries through antenatal and delivery care, and breastfeeding: supporting infant survival by supporting women's survival

1 reference

12 December 2020

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

1 reference

12 December 2020

The transmission dynamics of human immunodeficiency virus (HIV).

1 reference

12 December 2020

Update on perinatal HIV transmission

1 reference

12 December 2020

The lifetime cost of treating a person with HIV.

1 reference

12 December 2020

The role of mathematical models in the study of HIV transmission and the epidemiology of AIDS.

1 reference

12 December 2020

Poor nations ravaged by AIDS need the right resources now

1 reference

12 December 2020

Sexual transmission of HIV.

1 reference

12 December 2020

Modelling AIDS reduction strategies

1 reference

12 December 2020

Social network characteristics and injecting HIV-risk behaviors among street injection drug users

1 reference

12 December 2020

Economic impact of HIV infection and coronary heart disease in immigrants to Canada

1 reference

12 December 2020

A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective

1 reference

12 December 2020

Dynamic multidrug therapies for HIV: a control theoretic approach.

1 reference

12 December 2020

Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV).

1 reference

12 December 2020

Modeling the impact and cost-effectiveness of HIV prevention efforts

1 reference

12 December 2020

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

12 December 2020

A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.

1 reference

12 December 2020

The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection

1 reference

12 December 2020

Control of infectious diseases.

1 reference

12 December 2020

Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis

1 reference

12 December 2020

Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk

1 reference

12 December 2020

The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States

1 reference

12 December 2020

Who should be screened for HIV infection? A cost-effectiveness analysis

1 reference

12 December 2020

Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening

1 reference

12 December 2020

Changes in network characteristics and HIV risk behavior among injection drug users

1 reference

12 December 2020

The economics of heroin treatment

1 reference

12 December 2020

Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients

1 reference

12 December 2020

Blood safety in developing countries

1 reference

12 December 2020

Strategies for universalistic and targeted HIV prevention

1 reference

12 December 2020

The affordability of antiretroviral therapy in developing countries: what policymakers need to know

1 reference

12 December 2020

A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients.

1 reference

12 December 2020

Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable

1 reference

12 December 2020

Lamivudine reduces healthcare resource use when added to zidovudine-containing regimens in patients with HIV infection

1 reference

12 December 2020

HIV partner notification: taking a new look.

1 reference

12 December 2020

The demographic impact of AIDS in sub-Saharan Africa: short- and long-term projections

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011418614557

1 reference

1 August 2017

1 reference